Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study

This multi-center, retrospective study aimed to clarify the factors affecting drug retention of the Janus kinase inhibitors (JAKi) including baricitinib (BAR) and tofacitinib (TOF) in patients with RA. Patients were as follows; females, 80.6%; age, 60.5 years; DAS28-ESR, 4.3; treated with either BAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebina, Kosuke, Hirano, Toru, Maeda, Yuichi, Yamamoto, Wataru, Hashimoto, Motomu, Murata, Koichi, Onishi, Akira, Jinno, Sadao, Hara, Ryota, Son, Yonsu, Amuro, Hideki, Takeuchi, Tohru, Yoshikawa, Ayaka, Katayama, Masaki, Yamamoto, Keiichi, Okita, Yasutaka, Hirao, Makoto, Etani, Yuki, Kumanogoh, Atsushi, Okada, Seiji, Nakata, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742057/
https://www.ncbi.nlm.nih.gov/pubmed/34997059
http://dx.doi.org/10.1038/s41598-021-04075-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742057/
https://www.ncbi.nlm.nih.gov/pubmed/34997059
http://dx.doi.org/10.1038/s41598-021-04075-0

Ejemplares similares